Improved sensorimotor function by rolipram following focal cerebral ischemia in rats

Restorative Neurology and Neuroscience

Volumn 26, Issue 6, 2008, Pages 493-499

  Hätinen, Sonja ^a   Sairanen, Mikko ^b   Sirviö, Jouni ^b   Jolkkonen, Jukka ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b ORION CORPORATION   (Finland)

Author keywords

Behavioral recovery; focal cerebral ischemia; PDE4 inhibition; rolipram

Indexed keywords

PHOSPHODIESTERASE INHIBITOR; ROLIPRAM;

ANIMAL; ARTICLE; BRAIN ISCHEMIA; CONVALESCENCE; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; MALE; METHODOLOGY; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; RAT; ROTAROD TEST; TIME; WISTAR RAT;

ANIMALS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MOTOR ACTIVITY; PHOSPHODIESTERASE INHIBITORS; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; ROLIPRAM; ROTAROD PERFORMANCE TEST; TIME FACTORS;

EID: 64049097552     PISSN: 09226028     EISSN: 18783627     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Atkins, C.M., Oliva Jr, A.A., Alonso, O.F., Pearse, D.D., Bramlett, H.M., Dietrich, W.D. (2007). Modulation of the cAMP signaling pathway after traumatic brain injury. Exp Neurol, 208, 145-158.
2. Barth, A.L., McKenna, M., Glazewski, S., Hill, P., Impey, S., Storm, D., Fox, K. (2000). Upregulation of cAMP response element-mediated gene expression during experiencedependent plasticity in adult neocortex, J Neurosci, 20, 4206- 4216.
3. De Ryck, M., Van-Reempts, J., Borgers, M., Wauquier, A., & Janssen, P.A. (1989). Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats, Stroke, 20, 1383-1390.
4. Goldstein, L.B. (2000). Effects of amphetamines and small related molecules on recovery after stroke in animals and man, Neuropharmacology, 39, 852-859.
5. Gong, B., Vitolo, O.V., Trinchese, F., Liu, S., Shelanski, M., Arancio, O. (2004). Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J Clin Invest, 114, 1624-1634.
6. Hannila, S.S., Filbin, M.T. (2008). The role of cyclic AMP signaling in promoting axonal regeneration after spinal cord injury. Exp Neurol, 209, 32-32.
7. Imanishi, T., Sawa, A., Ichimaru, Y., Miyashiro, M., Kato, S., Yamamoto, T., Ueki, S. (1997). Ameliorating effects of rolipram on experimentally induced impairments of learning and memory in rodents. Eur J Pharmacol, 321, 273-278.
8. Jolkkonen, J., Puurunen, K., Rantak?omi, S., H?ark?onen, A., Haapalinna, A., Sivenius, J. (2000). Behavioral effects of the α2-adrenoceptor antagonist, atipamezole, after focal cerebral ischemia in rats. Eur J Pharmacol, 400, 211-219.
9. Karhunen, H., Virtanen, T., Schallert, T., Sivenius, J.,&Jolkkonen, J. (2003). Forelimb use after focal cerebral ischemia in rats treated with an α2-adrenoceptor antagonist. Pharmacol Biochem Be, 74, 663-669.
10. Krause, W., Kuhne, G. (1988). Pharmacokinetics of rolipram in the rhesus and cynomolgus monkeys, the rat and the rabbit. Studies on species differences. Xenobiotica, 18, 561-571.
11. Li, L., Jiang, Q., Zhang, L., Ding, G., Gang Zhang, Z., Li, Q., Ewing, J.R., Lu, M., Panda, S., Ledbetter, K.A., Whitton, P.A., & Chopp, M. (2007). Angiogenesis and improved cerebral blood flow in the ischemic boundary area detected by MRI after administration of sildenafil to rats with embolic stroke. Brain Res, 1132, 185-192.
12. Longa, Z.E., Weinstein, P.R., Carlson, S., Cummins, R. (1989). Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke, 20, 84-91.
13. MacDonald, E., van der Lee, H., Pocock, D., Cole, C., Thomas, N., VandenBerg, P.M., Bourtchouladze, R., Kleim, J.A. (2007). A novel phosphodiesterase type 4 inhibitor, HT-0712, enhances rehabilitation-dependent motor recovery and cortical reorganization after focal cortical ischemia. Neurorehab Neural Re, 21, 486-496.
14. Menniti, F.S., Faraci, W.S., Schmidt, C.J. (2006). Phosphodiesterases in the CNS: targets for drug development. Nature Reviews Drug Discovery, 5, 660-670.
15. Nagakura, A., Niimura, M., Takeo, S. (2002). Effects of a phosphodiesterase IV inhibitor rolipram on microsphere embolisminduced defects in memory function and cerebral cyclic AMP signal transduction system in rats. Brit J Pharmacol, 135, 1783-1793.
16. Nakagawa, S., Kim, J.E., Lee, R., Malberg, J.E., Chen, J., Steffen, C., Zhang, Y.J., Nestler, E.J., Duman, R.S. (2002). Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. J Neurosci, 22, 3673-3682.
17. Nikulina, E., Tidwell, J.L., Dai, H.N., Bregman, B.S., Filbin, M.T. (2004). The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery. Proceedings of the National Academy of Sciences, 101, 8786-8790.
18. Nudo, R.J., Wise, B.M., Sifuentes, F., Milliken, G.W. (1996). Neural substrates for the effects of rehabilitative training on motor recovery after ischemic infarct. Science, 272, 1791- 1794.
19. Puurunen, K., Jolkkonen, J., Sirvi?o, J., Haapalinna, A., Sivenius, J. (2001). An α2-adrenergic antagonist, atipamezole, facilitates behavioral recovery after focal cerebral ischemia in rats. Neuropharmacology, 40, 597-602.
20. Renau, T.E. (2004). The potential of phosphodiesterase 4 inhibitors for the treatment of depression: opportunities and challenges. Current Opinion in Investigational Drugs, 5, 34-39.
21. Sasaki, T., Kitagawa, K., Omura-Matsuoka, E., Todo, K., Terasaki, Y., Sugiura, S., Hatazawa, J., Yagita, Y., Hori, M. (2007). The phosphodiesterase inhibitor rolipram promotes survival of newborn hippocampal neurons after ischemia. Stroke, 38, 1597-1605.
22. Schallert, T., Woodlee, M.T. (2005). Orienting and placing. In: Whishaw, I.Q., Kolb, B. (Ed.), Behavior of the Laboratory Rat. A Handbook with Tests. New York: Oxford University Press, pp. 129-140.
23. Silvestre, J.S., Ferńandez, A.G., Palacios, J.M. (1999). Preliminary evidence for an involvement of the cholinergic system in the sedative effects of rolipram in rats. Pharmacol Biochem Be, 64, 1-5.
24. Whyte, E.M., Mulsant, B.H. (2002). Post stroke depression: epidemiology, pathophysiology, and biological treatment. Biol Psychiat, 52, 253-264.
25. Zhang, H-T., Zhao, Y., Huang, Y., Dorairaj, N.R., Chandler, L.J., & O'Donnell, J.M. (2004). Inhibition of the phosphodiesterase 4 (PDE4) enzyme reverses memory deficits produced by infusion of the MEK inhibitor U0126 into the CA1 subregion of the rat hippocampus. Neuropsychopharmacol, 29, 1432-1439.
26. Zhang, H-T., Huang, Y., Suvarna, N.U., Deng, C., Crissman, A.M., Hopper, A.T., De Vito, M., Rose, G.M., O'Donnell, J.M. (2005). Effects of the novel PDE4 inhibitors MEM1018 and MEM1091 on memory in the radial-arm maze and inhibitory avoidance tests in rats. Psychopharmacology, 179, 613-619.
27. Zhao, C-s., Puurunen, K., Schallert, T., Sivenius, J., Jolkkonen, J. (2005). Effect of cholinergic medication, before and after focal photothrombotic ischemic cortical injury, on histological and functional outcome in aged and young adult rats. Behav Brain Res, 156, 85-94.